1. Contractors
  2. Aapharmasyn LLC

Aapharmasyn LLC

Federal contractor · Research and Development in Biotechnology (except Nanobiotechnology)

Aapharmasyn has 2 federal contracts of $100,000 or more active since October 2023, with $728K obligated, from 1 agency. 1 is still running, 1 ending within 18 months.

Contracts
2 since FY2024$728,079 obligated, contracts of $100,000 or more
Running now
1 contract1 ended in the last 12 months
Biggest customer
National Institutes of Health$728K on 2 contracts
UEI
YUFFPW8FVKX2Unique entity ID in SAM.gov
Source
USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC

Running contracts

Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.

ContractObligatedEndsState
Interventional Agents Chemistry ServicesNational Institutes of Health · 75N93026F00002$580,843Mar 23, 2027in 4 monthsMI

End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.

Who they work for

AgencyAmount
National Institutes of Health2 contracts$728,079

What they sell

IndustryAmount
Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 · 2 contracts$728,079

Where the work is

Place of workAmount
Michigan2 contracts$728,079

Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at National Institutes of Health: see the list.

Get new notices like Aapharmasyn's work

New contract opportunities under NAICS 541714, research and development in biotechnology (except nanobiotechnology), the morning they appear. Free while in beta.

Free. We use your email only for these alerts and never share it. Privacy